Assess expected benefit from hypertension, hypervolemia, hemodilution for SAH-related vasospasm. Current evidence favors euvolemia + induced hypertension.
Assess expected benefit from hypertension, hypervolemia, hemodilution for SAH-related vasospasm. Current evidence favors euvolemia + induced hypertension
Each component has a specific meaning:
Note: Interpret the triple-h sah result against the thresholds and context described above.
Enter the hypertension, hypervolemia, hemodilution for the scenario you are assessing. Assess expected benefit from hypertension, hypervolemia, hemodilution for SAH-related vasospasm. Current evidence favors euvolemia + induced hypertension. Use the triple-h sah result to inform your calculation.